PT1509530E - 2-tia-dibenzoazulenos como inibidores da producao do factor de necrose tumoral e intermediarios para a producao destes - Google Patents

2-tia-dibenzoazulenos como inibidores da producao do factor de necrose tumoral e intermediarios para a producao destes

Info

Publication number
PT1509530E
PT1509530E PT03745849T PT03745849T PT1509530E PT 1509530 E PT1509530 E PT 1509530E PT 03745849 T PT03745849 T PT 03745849T PT 03745849 T PT03745849 T PT 03745849T PT 1509530 E PT1509530 E PT 1509530E
Authority
PT
Portugal
Prior art keywords
production
necrosis factor
dibenzoazulenes
intermediaries
tia
Prior art date
Application number
PT03745849T
Other languages
English (en)
Inventor
Mercep Mladen
Mesic Milan
Pesic Dijana
Ozimec Ivana
Original Assignee
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Istrazivacki Inst D O O filed Critical Pliva Istrazivacki Inst D O O
Publication of PT1509530E publication Critical patent/PT1509530E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C07D333/80Seven-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT03745849T 2002-04-10 2003-04-09 2-tia-dibenzoazulenos como inibidores da producao do factor de necrose tumoral e intermediarios para a producao destes PT1509530E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR20020305A HRP20020305A8 (en) 2002-04-10 2002-04-10 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof

Publications (1)

Publication Number Publication Date
PT1509530E true PT1509530E (pt) 2006-07-31

Family

ID=28686903

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03745849T PT1509530E (pt) 2002-04-10 2003-04-09 2-tia-dibenzoazulenos como inibidores da producao do factor de necrose tumoral e intermediarios para a producao destes

Country Status (26)

Country Link
US (1) US7435834B2 (pt)
EP (1) EP1509530B1 (pt)
JP (1) JP2005526828A (pt)
CN (1) CN1649875A (pt)
AT (1) ATE320433T1 (pt)
AU (1) AU2003259963A1 (pt)
BR (1) BR0309094A (pt)
CA (1) CA2481514A1 (pt)
CY (1) CY1105036T1 (pt)
DE (1) DE60304048T2 (pt)
DK (1) DK1509530T3 (pt)
ES (1) ES2260637T3 (pt)
HR (1) HRP20020305A8 (pt)
IL (1) IL164396A0 (pt)
IS (1) IS7474A (pt)
MX (1) MXPA04009943A (pt)
NO (1) NO20044506L (pt)
NZ (1) NZ535620A (pt)
PL (1) PL372748A1 (pt)
PT (1) PT1509530E (pt)
RU (1) RU2334749C2 (pt)
SI (1) SI1509530T1 (pt)
UA (1) UA79277C2 (pt)
WO (1) WO2003084962A1 (pt)
YU (1) YU88304A (pt)
ZA (1) ZA200408063B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020304B1 (en) * 2002-04-10 2008-04-30 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
HRP20020452A2 (en) * 2002-05-23 2004-02-29 Pliva D D 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20030885A2 (en) * 2003-11-03 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS
HRP20030956A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU
EP1968583A4 (en) * 2005-12-20 2010-09-15 Harvard College COMPOUNDS, SCREENING AND TREATMENT PROCEDURES

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711489A (en) * 1971-03-31 1973-01-16 Pfizer Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles
CA967573A (en) 1972-12-22 1975-05-13 Joseph G. Lombardino Tetracyclic anti-inflammatory agents
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.
US4198421A (en) * 1978-11-30 1980-04-15 E. I. Du Pont De Nemours And Company Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles
FR2504140A1 (fr) 1981-04-16 1982-10-22 Centre Nat Rech Scient Nouveaux derives tetracycliques de la dibenzazepine, leur procede de preparation et les compositions pharmaceutiques en renfermant
FI841399A7 (fi) 1983-04-12 1984-10-13 Ciba Geigy Ag Polysykliset karboksyylihappoyhdisteet, menetelmä niiden valmistamiseksi ja näitä karboksyylihappoyhdisteitä sisältävät valmisteet sekä niiden käyttö.
IE62754B1 (en) 1988-08-26 1995-02-22 Akzo Nv Tetracyclic antidepressants
IT1227527B (it) 1988-12-05 1991-04-12 Ciatti Maurizio Spazzolino da denti a setole rotanti
RU2161159C2 (ru) 1994-11-02 2000-12-27 Жансен Фармасетика Н.В. Замещенные тетрациклические производные оксазепина и тиазепина, способ их получения, композиция, обладающая антипсихотической активностью, и способ ее получения
US5552399A (en) 1994-11-02 1996-09-03 Janssen Pharmaceutica N.V. Substituted tetracyclic azepine derivatives
ES2196328T3 (es) 1996-04-12 2003-12-16 Janssen Pharmaceutica Nv Derivados de tetrahidrofurano tetraciclicos sustituidos.
UA52778C2 (uk) * 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
HRP20000310A2 (en) 2000-05-17 2002-02-28 Pliva Farmaceutska Ind Dioniko New dibenzoazulene compounds as tumor necrosis factor inhibitors
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20030957A2 (en) 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-THIA-3-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20040104A2 (en) 2004-01-30 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders

Also Published As

Publication number Publication date
UA79277C2 (en) 2007-06-11
DE60304048T2 (de) 2006-10-19
US20050182126A1 (en) 2005-08-18
JP2005526828A (ja) 2005-09-08
ZA200408063B (en) 2006-07-26
EP1509530B1 (en) 2006-03-15
US7435834B2 (en) 2008-10-14
MXPA04009943A (es) 2005-09-30
NZ535620A (en) 2006-03-31
DE60304048D1 (de) 2006-05-11
IS7474A (is) 2004-09-27
ATE320433T1 (de) 2006-04-15
HRP20020305A8 (en) 2009-03-31
CN1649875A (zh) 2005-08-03
DK1509530T3 (da) 2006-07-17
AU2003259963A1 (en) 2003-10-20
RU2004132868A (ru) 2005-06-10
RU2334749C2 (ru) 2008-09-27
NO20044506L (no) 2004-11-09
IL164396A0 (en) 2005-12-18
HRP20020305A2 (en) 2003-10-31
WO2003084962A1 (en) 2003-10-16
ES2260637T3 (es) 2006-11-01
CY1105036T1 (el) 2010-03-03
SI1509530T1 (sl) 2006-08-31
BR0309094A (pt) 2005-02-09
PL372748A1 (en) 2005-08-08
CA2481514A1 (en) 2003-10-16
EP1509530A1 (en) 2005-03-02
YU88304A (sh) 2006-08-17

Similar Documents

Publication Publication Date Title
HN2002000067A (es) Inhibidores de la rho - quinasa.
MX368368B (es) Compuestos de indol e indazol como un inhibidor de necrosis celular.
EA200702339A1 (ru) Замещенные амидные производные в качестве ингибиторов протеинкиназы
NO20045589L (no) Nye forbindelser
UY28310A1 (es) Pirazoles como inhibidores de factor de necrosis tumoral
PT1509530E (pt) 2-tia-dibenzoazulenos como inibidores da producao do factor de necrose tumoral e intermediarios para a producao destes
BR0309097A (pt) Benzonaftoazulenos como inibidores de produção de fator de necrose de tumor e intermediários para a sua preparação
PT1492797E (pt) 1-oxa-3-aza-dibenzoazulenos como inibidores da producao do factor de necrose tumoral e intermediarios para a producao destes
EA200801107A1 (ru) Пиразолы, пригодные для лечения воспалений
WO2003097649A3 (en) 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
PL1732926T3 (pl) Inhibitory kinezyn motorycznych
WO2003099823A3 (en) 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
ATE536101T1 (de) Behandlung heilmittelresistenter proliferativer erkrankungen
BRPI0512832A (pt) composto ou um sal ou estereoisÈmero farmaceuticamente aceitável do mesmo, composição farmacêutica, e, método para usar um composto
HN2003000110A (es) Nuevos derivados de indol como inhibidores del factor xa